Effects of Amino Acid Infusion on Amniotic Fluid Volume and Perinatal Outcomes in Oligohydramnios Patients: An Evidence-Based Case Report
e-CliniC · 03.08.2026 · 14 (2) · 356-364
DOI: 10.35790/yqg6v656 ↗Kurz gefasst
Fallbericht in der Zeitschrift e-CliniC, online erschienen am 03.08.2026. Verfasst von Christi G. A. Hanafi und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Oligohydramnios is associated with perinatal morbidity and mortality. Intravenous (IV) amino acid infusion is a proposed management strategy to improve amniotic fluid volume and fetal nutrition. This evidence-based case report evaluates the efficacy of IV amino acid infusion versus standard IV hydration on Amniotic Fluid Index (AFI) and perinatal outcomes. This was a systematic search conducted on PubMed, Scopus, Cochrane, and Google Scholar for randomized controlled trials or semi-experimental studies. Critical appraisal was performed using OCEBM criteria. The results showed that literature screening process yielded three eligible studies, comprising one RCT and two semi-experimental studies. Two of these studies reported a statistically significant increase in AFI among patients in the amino acid infusion group (p
Zitieren
APA
Hanafi, C. G. A., & Lestari, W. (2026). Effects of Amino Acid Infusion on Amniotic Fluid Volume and Perinatal Outcomes in Oligohydramnios Patients: An Evidence-Based Case Report. e-CliniC, 14(2), 356-364. https://doi.org/10.35790/yqg6v656
Vancouver
Hanafi CGA, Lestari W. Effects of Amino Acid Infusion on Amniotic Fluid Volume and Perinatal Outcomes in Oligohydramnios Patients: An Evidence-Based Case Report. e-CliniC. 2026;14(2):356-364. doi:10.35790/yqg6v656
BibTeX
@article{Hanafi2026,
author = {Hanafi, Christi G. A. and Lestari, Wiji},
title = {Effects of Amino Acid Infusion on Amniotic Fluid Volume and Perinatal Outcomes in Oligohydramnios Patients: An Evidence-Based Case Report},
journal = {e-CliniC},
year = {2026},
volume = {14},
number = {2},
pages = {356--364},
doi = {10.35790/yqg6v656}
}
EUVIMED